CSL expands public reimbursement for ANDEMBRY in Quebec and Alberta
CSL said ANDEMBRY (garadacimab) now has public reimbursement in Quebec and Alberta, plus coverage via federal NIHB and Veterans Affairs Canada for eligible HAE patients.
CSL said ANDEMBRY (garadacimab) now has public reimbursement in Quebec and Alberta, plus coverage via federal NIHB and Veterans Affairs Canada for eligible HAE patients.